Background: Platelet-derived growth factor (PDGF) triggers cytoskeletal rearrangements and chemotaxis within minutes. These events are at least in part due to the activation of phosphoinositide (PI) 3-kinase; there is good temporal correlation between these events and the accumulation of 3-phosphorylated products of the kinase. Prolonged and continuous PDGF exposure results in S-phase entry many hours after the initial burst of activity. Although early signals appear responsible for the early responses, they may not fully account for later responses, such as cell-cycle progression.
Background
Exposure of cells to growth factors such as platelet-derived growth factor (PDGF) leads to a variety of cellular responses that occur at different times after stimulation. For instance, minutes after adding PDGF, the cell membrane begins to ruffle and the cell may send out filopodia ( [1] [2] [3] [4] [5] ; reviewed in [6] ). The basis for these morphological changes is a reorganization of the actin cytoskeleton, which is driven by PDGF-initiated signaling events. One of the enzymes that has been identified to play a key role in these events is phosphoinositide (PI) 3-kinase [7] [8] [9] [10] [11] , which is both a protein kinase and lipid kinase [12, 13] . The PI 3-kinase isoforms that are responsive to polypeptide growth factors are composed of a p85 adapter protein and a p110 catalytic subunit (reviewed in [14, 15] . PDGF-dependent activation of PI3K requires two events: association of PI 3-kinase with the phosphorylated PDGF receptor (PDGFR) as well as the presence of the activated form of the small GTPase Ras [16] [17] [18] . Once PI 3-kinase is activated, there is a rapid and transient accumulation of 3-phosphorylated lipid products, phosphatidylinositol-3,4,5-trisphosphate (PtdIns-3,4,5-P 3 ) and phosphatidylinositol-3,4-diphosphate (PtdIns-3,4-P 2 ).
These lipid products accumulate at the times when the cells are undergoing cytoskeletal rearrangements, and thus the early cellular responses to PDGF appear to be a direct consequence of PDGF-dependent signaling events that occur at this time. Indeed, synthetic 3-phosphorylated lipid products are able to induce cell motility [19] .
PDGF, like many other growth factors, also induces cellcycle progression. In quiescent cells, this includes exit from G0 phase, progression through G1 phase, and then entry into S phase, which happens approximately 8-12 hours after adding PDGF. A number of signaling enzymes are required for PDGF-dependent cell-cycle progression, and work from several groups indicates that there may be redundant pathways that drive these events [20] [21] [22] [23] [24] . The observation that growth-factor-stimulated cell-cycle progression requires the continuous presence of the growth factor for at least 6-8 hours [25] [26] [27] suggests that there are signaling events that occur throughout this time period. Curiously, the activity of many signaling enzymes begins to wane 30-60 minutes after exposure to PDGF. This may be because the receptor is internalized and degraded, and because enzymes that can reverse the initial activation become active. For instance, even in the continued presence of PDGF, the initial burst of activity of the mitogen-activated protein (MAP) kinase Erk recedes, which is at least in part due to PDGF-dependent activation of MAP kinase phosphatases that inactivate Erk [28, 29] . For late PDGF-dependent responses such as cell-cycle progression, therefore, the transient, early activation of signaling enzymes does not adequately explain the requirement for continuous exposure to PDGF for many hours.
A recent report from Taylor and Shalloway [30] has made the surprising observation that, in the continuous presence of growth factors, the early and transient activation of Ras is followed by an accumulation of Ras approximately 4 hours later. Earlier studies have shown that there are two distinct times during G1 phase when Ras activity is needed for cell-cycle progression: an early time, corresponding to the initial burst of Ras activity, and a point later in the cell cycle [31, 32] . These findings indicate that Ras is activated at multiple times during G1 phase and that the G1-to S-phase transition requires the accumulation of active Ras at both of these times.
Progression through G1 phase may also require PI3K activity several hours after exposure to growth factors. Microinjection of neutralizing antibodies against the p110α (but not p110β) form of the PI3K catalytic subunit several hours after stimulation of cells with PDGF suppresses PDGF-dependent DNA synthesis [33] [34] [35] . Addition of PI3K inhibitors blocks growth-factor-dependent or serum-dependent cell-cycle progression in mid-G1 phase, and these events correlate with impaired degradation of the cyclin-dependent-kinase inhibitor p27 Kip1 [36] [37] [38] . These observations suggest that PI3K activity is not restricted to the first 60 minutes after stimulation, and that activation of PI3K may be required for cell-cycle progression. Yet PI3K activity has not been detected at times later than the G0-G1 transition. Furthermore, failure to activate PI3K at this early time point correlates well with the inability to proceed through the cell cycle [20, 23, 33 ].
In the experiments described here, we tested the idea that there is a second wave of PI3K activity before cells enter S phase. We also developed a novel assay to evaluate the relative importance of the temporally distinct waves of PI3K products for PDGF-dependent cell-cycle progression.
Results

PDGF induces two waves of 3-phosphorylated lipid products
We investigated whether PDGF triggers more than the early burst of PI3K activity. Resting HepG2 cells expressing the wild-type β subunit of the PDGFR were labeled with [ 32 P]H 3 PO 4 , stimulated with PDGF and harvested, the phospholipids were extracted, and 3-phosphorylated lipid products were analyzed by high-performance liquid chromatography (HPLC). As expected from previously published reports [39, 40] , PtdIns-3,4-P 2 and PtdIns-3,4,5-P 3 accumulated rapidly and transiently 5-30 minutes after PDGF stimulation (Figure 1 ). The level of PtdIns-3,4-P 2 decreased substantially at around 30 minutes and remained low until approximately 3 hours after PDGF stimulation. PtdIns-3,4,5-P 3 levels also subsided, but not as much as those of PtdIns-3,4-P 2 . After 3 or 4 hours of continuous exposure to PDGF, the cellular levels of PtdIns-3,4,5-P 3 and PtdIns-3,4-P 2 began to increase (Figure 1 ). This second wave of 3-phosphorylated products was much broader than the initial peak and lasted until approximately 7 hours after PDGF stimulation. The ratio of the two PI 3-kinase products was comparable in the two peaks. In contrast to the increase in PI 3-kinase products, the levels of PtdIns-4,5-P 2 did not markedly change at any of the time points (Figure 1 ). PDGF thus induces two distinct waves of PI 3-kinase products, and the second phase of PI 3-kinase activity is substantially longer than the initial one.
Synthetic 3-phosphorylated lipids rescue PDGF-dependent DNA synthesis
Using several different experimental approaches, a number of labs have concluded that PI 3-kinase is required for PDGF-dependent DNA synthesis [20, 23, 33] . Our findings that there are two distinct times at which PI 3-kinase products accumulate as cells move through G0 and G1 phase beg the question of when the cell needs Research Paper PDGF induces an early and late wave of PI 3-kinase activity Jones et al. 513
Figure 1
PDGF induces two waves of 3-phosphorylated lipid products. Quiescent HepG2 cells expressing the wild-type βPDGFR were stimulated with PDGF-BB (50 ng/ml) for increasing periods of time (0-8 h), and labeled with [ 32 P]orthophosphate as described in the Materials and methods section. The cells were harvested and the phospholipids were extracted, deacylated and then separated by HPLC. The amount of radiolabeled PtdIns-3,4-P 2 and PtdIns-3,4,5-P 3 was determined, normalized to the amount of PtdIns-4-P, and the resulting data (in disintegrations per minute, dpm) plotted as a function of the duration of PDGF stimulation. The levels of PtdIns-4,5-P 2 are shown. The data points are the mean of two independent experiments; the range between the points from the two experiments was not more than 10% of the mean. 1,000,000 1,500,000 2,000,000 PtdIns-3,4-P 2 and PtdIns-3,4,5-P 3 (dpm) PtdIns-3, 4,5-P 3
PtdIns-3,4-P 2
PtdIns-4,5-P 2 PI 3-kinase in order to proceed to S phase. An additional question is the importance of the lipids themselves. PI 3-kinase is both a lipid kinase and protein kinase, and these two activities appear to make distinct contributions to the overall signaling output of PI 3-kinase [41] . The approaches employed to date have not revealed whether it is the lipid or protein kinase activity of PI 3-kinase that is required for cell-cycle progression.
To begin to address these questions, we developed a new strategy to investigate whether and when PI 3-kinase lipid products are needed for progression through G1 phase and into S phase. This approach consisted of using synthetic 3-phosphorylated lipids to rescue PDGF-dependent DNA synthesis in cells expressing an F5 βPDGFR mutant. This receptor has phenylalanines in place of the tyrosines that are required for binding PI 3-kinase (Tyr740 and Tyr751), the Ras GTPase-activating protein (RasGAP; Tyr771), the protein tyrosine phosphatase SHP-2 (Tyr1009) and phospholipase Cγ (PLCγ; Tyr1021) and fails to initiate PDGF-dependent DNA synthesis when expressed in HepG2 cells [42] .
If the synthetic 3-phosphorylated lipids were added directly to a culture of cells expressing F5 βPDGFR, they did not rescue PDGF-dependent DNA synthesis (data not shown). A likely explanation is that the lipids are not properly oriented in the lipid bilayer. We therefore developed a protocol to permeabilize the cells and thereby allow entry of the synthetic PI 3-kinase products. To determine an optimum concentration of the permeabilizing agent, saponin, the effect of transient exposure to increasing concentrations of saponin on serum-dependent DNA synthesis was measured. At the higher concentrations of saponin, the DNA-synthesis response was compromized, whereas concentrations of 0.025 mg/ml and 0.05 mg/ml did not prevent cell-cycle progression ( Figure 2a ). Using 0.05 mg/ml saponin, we tested whether adding the PI 3-kinase lipid products would allow DNA synthesis. We found that PDGF-dependent DNA synthesis was rescued when dipalmitoyl (diC16) PtdIns-3,4-P 2 and diC16 PtdIns-3,4,5-P 3 were added together ( Figure 2b ). When cells were incubated with the synthetic lipids in concentrations of saponin less than 0.05 mg/ml, they were unable to synthesize DNA, suggesting that a critical concentration of saponin was required for the entry of lipids into the cells (data not shown). DiC16 PtdIns-3,4,5-P 3 alone could partially rescue DNA synthesis, whereas several concentrations of diC16 PtdIns-3,4-P 2 could not ( Figure 2b ). In addition, 1-25 µM PtdIns-4,5-P 2 was unable to rescue DNA synthesis (data not shown). These studies indicate that lipid products of PI 3-kinase are able to promote PDGFdependent cell-cycle progression and that PtdIns-3,4,5-P 3 is more effective than PtdIns-3,4-P 2 . Furthermore, 3-phosphorylated lipids were not able to drive DNA synthesis in the absence of PDGF, suggesting that PDGF initiates signaling events that make an essential contribution (see below). Finally, PDGF-dependent DNA synthesis was rescued when the lipids were added at times corresponding to the second wave of PI 3-kinase products ( Figure 1 ). Thus, an accumulation of PI 3-kinase products Because lipid rescue was dependent on PDGF, and the cells that were used expressed only the F5 βPDGFR, it appears that the F5 receptor was able to initiate events that were required for cell-cycle progression. This receptor does not activate PI 3-kinase, [42] , suggesting that the early peak of PI 3-kinase activity is dispensable for PDGFdependent cell-cycle progression. To further evaluate the relative importance of the early and late waves of PI 3-kinase activity, we tested the effect of PI 3-kinase inhibitors on PDGF-dependent DNA synthesis. For these experiments, we focused on cells expressing the Y40/51 βPDGFR, which recruits and activates PI 3-kinase but not many of the other signal relay enzymes that are engaged by the wild-type βPDGFR [42] . PI 3-kinase inhibitors (wortmannin and LY294002) added before PDGF, or up to 30 minutes after PDGF, had no effect on PDGF-dependent DNA synthesis (Figure 3a and data not shown). Previous studies have indicated that administering the drugs at these times blocks the first wave of PI 3-kinase activity [16, [43] [44] [45] [46] . In contrast, the inhibitors effectively blocked PDGF-dependent DNA synthesis when they were added 1-7 hours after PDGF, and LY294002 consistently inhibited earlier than wortmannin did (Figure 3a) . When the drug-treated cells were treated as in the lipid-rescue assay, we found that the synthetic 3-phosphorylated lipids (the combination of PtdIns-3,4,5-P 3 and PtdIns-3,4-P 2 ) reversed the block in DNA synthesis (data not shown), suggesting that the PI 3-kinase inhibitors exert their effects by preventing the accumulation of PI 3-kinase products. The experiments described in this section are consistent with the idea that the early wave of PI 3-kinase activity is not required for DNA synthesis, and that cells must accumulate 3-phosphorylated products hours after PDGF stimulation in order to respond.
Wortmannin has a short half-life in HepG2 cells
A problem with interpreting the data in Figure 3a is that if PI 3-kinase products were required at the late time points, then early addition of PI 3-kinase inhibitors should also have blocked the response. This raises the question of the stability of the inhibitors; in the case of wortmannin, previous studies have shown that it has a relatively short halflife [47, 48] . To define the half-life of wortmannin in HepG2 cells, cells expressing the wild-type βPDGFR were treated with wortmannin for increasing lengths of time (up to 4 hours) and, during the final 10 minutes of the incubation, PDGF was added to activate the receptor. The cells were lysed, the receptor was immunoprecipitated and the receptor-associated PI 3-kinase activity was assayed in vitro ( Figure 4a) . We found that 100 nM wortmannin was able to completely inhibit the receptor-associated PI 3-kinase activity, provided that the drug was not left on the cells for more than 1 hour. Receptor immunoprecipitates from cells incubated with wortmannin for more than 1 hour had detectable PI 3-kinase activity, and once wortmannin had been on the cells for 2-3 hours, it was no longer able to inhibit PI 3-kinase activity that was recruited to the receptor. Control experiments indicated that wortmannin did not alter the amount of p85 that couples to the receptor (Figure 4b ), the extent of receptor tyrosine phosphorylation (Figure 4c ), or the amount of receptor that could be immunoprecipitated (Figure 4d) . Note that the variability in receptor level seen in this experiment were not consistently observed (data not shown). Comparable experiments could not be performed with LY294002 because it Research Paper PDGF induces an early and late wave of PI 3-kinase activity Jones et al. 515 The effect of PI 3-kinase inhibitors on PDGF-dependent DNA synthesis. HepG2 cells expressing (a) the Y40/51 βPDGFR, (b) the wild-type βPDGFR or (c) the Y1021 βPDGFR were exposed to buffer or PDGF at time 0, and the PI 3-kinase inhibitor wortmannin (100 nM) or LY294002 (50 µM) was added at the indicated times. does not covalently bind to PI 3-kinase and, consequently, washing of the immunoprecipitates reverses the effect of LY294002 [46, 49] . These data show that wortmannin is able to completely inhibit PDGFR-associated PI 3-kinase activity for only 1 hour, and that after 3-4 hours, receptorassociated PI 3-kinase activity recovers to near maximal levels in the wortmannin-treated cells. Thus, the short half-life of wortmannin, 90 minutes, is a likely explanation of why early addition of wortmannin did not block PDGFdependent DNA synthesis.
PI 3-kinase inhibitors cause a delay in S-phase entry
Two different experimental approaches support that idea that PI 3-kinase products must accumulate hours after exposure to PDGF in order for the cells to reach S phase. Given the role of PI 3-kinase in protecting cells from apoptosis ( [44, [50] [51] [52] [53] , reviewed in [54] ), it is possible that the PI 3-kinase products are needed late in G1 phase to protect from apoptosis at that stage. Alternatively, the late phase of PI 3-kinase activity could be needed for progression through G1 phase. To distinguish between these two possibilities, cells expressing the Y40/51 βPDGFR were treated with PDGF alone, or with PDGF followed by wortmannin 5 hours later. The cells were treated with a pulse of [ 3 H]thymidine, which is incorporated into newly synthesized DNA, for 2 hour intervals from 8 to 32 hours to identify the time of entry into S phase. In response to PDGF, cells began to enter S phase 8-10 hours after PDGF stimulation and the peak of incorporation occurred at 12-18 hours ( Figure 5 ). Uptake of [ 3 H]thymidine tapered off and returned to background levels at approximately 22-24 hours and remained low for the next 6 hours. In cells that had been treated with PDGF and wortmannin, no increase in [ 3 H]thymidine incorporation was observed between 10 and 24 hours, but a later peak of incorporation occurred 26-32 hours after PDGF stimulation. The size of the peak was consistently smaller at the later time points, which may reflect the fact that the cells are becoming asynchronous. In addition, wortmannintreated cultures did not appear to be morphologically altered, and the overall number of cells did not change during the time course of these experiments (data not shown). These data indicate that the second wave of PI 3-kinase activity is not required to protect cells from apoptosis, and that it instead appears to be required for progression through G1 phase. 2 1 2 -1 4 1 4 -1 6 1 6 -1 8 1 8 -2 0 2 0 -2 2 2 2 -2 4 2 4 -2 6 2 6 -2 8 2 8 The time at which the wortmannin-treated cells finally do enter S phase suggests that the absence of PI 3-kinase activity in mid-to-late G1 phase results in a return to G0 phase. As seen in Figure 5 , exposure to wortmannin delayed S phase by much longer than the half-life of the drug. This is reminiscent of early findings that briefly depriving cycling cells of growth factors forces them into G0 phase [55] . We speculate that cells progress through much of G1 phase before they need PI 3-kinase products, and if this requirement is not satisfied, then they return to G0 phase.
Multiple ways to progress through G1 phase
Our findings indicate that PI 3-kinase activity in mid-G1 phase was required for PDGF-dependent entry into S phase. These experiments were done with cells expressing a receptor mutant that is able to use only a restricted subset of the many signaling pathways available to the wild-type receptor. To assess the importance of PI 3-kinase for cell-cycle progression in HepG2 cells expressing the wild-type receptor, we tested the ability of PI 3-kinase inhibitors to block PDGF-dependent DNA synthesis in such cells. Like the cells expressing a mutant receptor, the wild-type cells were sensitive to inhibitors, but only when the drugs were added 1-7 hours after PDGF (Figure 3b) . However, the inhibitors routinely inhibited about 20-30% of the response, which is consistent with the findings that PDGFRs that are unable to activate PI 3-kinase still initiate 50% or more of the wildtype response in a DNA-synthesis assay [10, 56] . PDGFdependent DNA synthesis was also partially inhibited by addition of wortmannin 1-7 hours after PDGF in NIH 3T3 cells, which naturally express the wild-type PDGFR (data not shown). These observations suggest that the PI 3-kinase pathway is not the only one by which cells can progress through G1 phase. We have previously found that receptors that activate PLCγ (but not PI 3-kinase) are able to progress to S phase [42] ; the PLCγ pathway may thus be one of the PI 3-kinase-independent routes through G1 phase. To investigate this idea, we tested whether cells expressing the Y1021 βPDGFR were sensitive to PI 3-kinase inhibitors [42] . PDGF-dependent DNA synthesis in these cells was not inhibited by either of the inhibitors at any of the times tested (Figure 3c ). These data indicate that there are multiple signaling enzymes capable of driving progression through G1 phase, and suggest that both PLCγ and PI 3-kinase are competent to initiate these events. Finally, they show that the PI 3-kinase inhibitors do not non-specifically block an enzyme or factor that is required for the synthesis of DNA.
Early addition of synthetic 3-phosphorylated lipid products does not rescue DNA synthesis
The PI 3-kinase-inhibitor experiments indicate that the first wave of PI 3-kinase activity is not required for DNA synthesis, because adding the inhibitors early does not prevent entry into S phase. In addition, the first peak does not appear to be sufficient, because the addition of the inhibitors after the first peak of activity blocks PDGFdependent DNA synthesis. Together, these findings indicate that the first peak of PI 3-kinase activity is dispensable for cell-cycle progression. We further investigated the importance of the first peak of PI 3-kinase products with the lipid-rescue assay. Adding the synthetic 3-phosphorylated lipids simultaneously with PDGF initiated DNA synthesis only slightly more than buffer alone ( Figure 6 ). Given that the PI 3-kinase products are metabolized and/or dephosphorylated rapidly (Figure 1 ), it is likely that when they are added early, they do not persist to mid-G1 phase. The best response was observed when the lipids were added to cells 6 hours after PDGF; addition of lipids 8 hours after PDGF, a time when PI 3-kinase products are no longer observed in cells (Figure 1) , did not initiate a response. Together, our data strongly suggest that, in contrast to the late phase of PI 3-kinase activity, the early accumulation of PI 3-kinase products is not a requirement for cell-cycle progression.
Discussion
We have found that in the continuous presence of PDGF, the lipid products of PI 3-kinase accumulated early (5-30 minutes after PDGF stimulation), and then again in mid-to-late G1 phase (3-7 hours after PDGF stimulation). Two independent approaches were used to evaluate the importance of each of the waves of PI 3-kinase activity for PDGF-dependent DNA synthesis, and revealed that the PI 3-kinase activity in mid-to-late G1 phase was required for cell-cycle progression, whereas the initial peak of PI 3-kinase activity was dispensable.
Figure 6
Temporal requirement for PI 3-kinase products in DNA synthesis. HepG2 cells expressing the F5 βPDGFR were assayed by lipid rescue as described in the Materials and methods section. At time 0, the cells were either left resting (white bars) or PDGF was added (gray bars). All cells were loaded with 25 µM diC16 PtdIns-3,4-P 2 and 25 mM diC16 PtdIns-3,4,5-P 3 at the indicated times. The data are presented as the fold increase in thymidine incorporation compared with buffertreated controls. How does accumulation of 3-phosphorylated lipid products promote progression through G1 phase? One possibility is that PI 3-kinase promotes the degradation of one of the inhibitors of the cyclin-dependent kinases. PDGF has been reported to decrease the level of p27 Kip1 [57, 58] . Furthermore, chronic administration of LY294002 blocks vascular smooth-muscle cells and choroid-melanoma cells late in G1 phase, and these events correlate with the inhibition of G1 cyclin-dependent kinases and sustained levels of the cyclin-dependent-kinase inhibitor p27 Kip1 [36, 37] . In NIH 3T3 cells, addition of wortmannin, or expression of a dominant-negative mutated form of Ras, p21 Ha-Ras(Asn17) late in G1 phase blocks EGF-dependent loss of p27 Kip1 and S-phase entry [38] . These data suggest that PI 3-kinase contributes to G1 progression at least in part by stimulating the degradation of cyclin-dependentkinase inhibitors.
An accumulation of PI 3-kinase products in mid-G1 phase is not the only way in which cells can progress through G1 phase. PI 3-kinase inhibitors only partially blocked PDGFdependent DNA synthesis in cells expressing the wildtype βPDGFR (Figure 3b ). Furthermore, PI 3-kinase inhibitors had no effect on PDGF-dependent cell-cycle progression in cells expressing the Y1021 receptor (Figure 3c ), which activates PLCγ but not PI 3-kinase [20, 42] . Thus, the βPDGFR is able to initiate PI 3-kinasedependent and PI 3-kinase-independent signaling enzymes that drive G1 progression, and it appears that PLCγ directs one of the PI 3-kinase-independent cascades.
The lipid-rescue assay revealed that PI 3-kinase products are unable to promote progression through G1 phase unless the cells have been stimulated with PDGF. One interpretation of these findings is that PDGF initiates signaling events that make the cells ready to respond to subsequent addition of lipids. Because the F5 receptor was capable of mediating this signal, it appears that PI 3-kinase, PLCγ, SHP-2, and RasGAP are not required. The F5 receptor retains the tyrosine residues that are required for binding and activation of Src, and Src may thus be responsible for mediating the early events. But receptor mutants that fail to activate Src are able to drive cell-cycle progression [59] [60] [61] . This leaves open the question of how the F5 βPDGFR makes the cells responsive to PI 3-kinase products later in G1 phase. We are currently exploring the role of the F5 βPDGFR in driving cells out of G0 phase.
Some investigators have found that PDGF is an incomplete mitogen, and only makes cells 'competent' -able to respond to other growth factors (progression factors) that drive cell-cycle progression [25, 26] . This characteristic of PDGF appears to be cell-type-dependent, as we and others have found that PDGF is a complete mitogen for a number of cell lines, including the HepG2 line used throughout these studies. Importantly, the F5 receptor is able to do more than just make cells competent. This is because competent cells require as much time to reach S phase as do G0-phase cells (at least 12 hours for 3T3 cells) [62] , whereas it takes only 4-6 hours for the PDGF-treated F5-βPDGFR-expressing cells to begin to synthesize DNA following addition of lipids (our unpublished observations). We postulate that the F5 receptor initiates exit from G0 phase and progression through the first half of G1 phase, and the lipids overcome a mid-tolate G1-phase checkpoint.
Our observations that PDGF induces the accumulation of distinct waves of PI 3-kinase lipid products may explain why constitutive activation of PI 3-kinase leads to abnormalities in cell-cycle progression and apoptosis [63] . The idea that temporal regulation of second messengers can alter the nature of a response has been well developed in the field of intracellular calcium signaling [64, 65] and appears to extend to the lipid products of PI 3-kinase as well. Indeed, the first wave of PI 3-kinase activity has been shown to be required for membrane ruffling and chemotaxis, both of which are early responses to mitogens [8, 7, 10, 11] . In contrast, this early phase of PI 3-kinase activity is dispensable for later events, such as DNA synthesis, which appears to be driven by the second wave of PI 3-kinase products. How PDGF induces two distinct waves of PI 3-kinase activity, and the identity of the PI 3-kinase effectors that are required for G1 progression, are being actively investigated.
Materials and methods
Materials
Wortmannin and LY294002 were purchased from Sigma and BioMol, respectively, and stored in DMSO at -80°C in small aliquots. Aliquots were defrosted once for use and the unused portion was discarded. Phosphatidylinositol and crude bovine-brain phosphoinositides were purchased from Avanti Polar Lipids. PDGF-BB was generously provided by Amgen.
Cell lines
The wild-type, Y40/51, Y1021 and F5 βPDGFR HepG2 cell lines were previously constructed and characterized [20] . Briefly, the F5 receptor has tyrosines 740, 751, 1009 and 1021 mutated to phenylalanine. The Y40/51 receptor is the same as F5, except the mutations at 740 and 751 have been repaired. Similarly, the Y1021 receptor has tyrosine in place of phenylalanine aat position 1021, wheras all the other mutations are as in F5. The F5 βPDGFR does not efficiently associate with PLCγ, RasGAP, PI 3-kinase or SHP-2 and fails to activate either PI 3-kinase or PLCγ. The Y40/51 and Y1021 βPDGFRs recruit and activate PI 3-kinase and PLCs respectively, and unlike the F5 βPDGFR, each of these add-back receptors are able to initiate a large fraction of the DNA synthesis response observed in cells expressing the wild-type βPDGFR.
In vivo analysis of PI 3-kinase products
To analyze PI 3-kinase products, cultures of HepG2 cells expressing the wild-type βPDGFR were first serum-starved for 24 h (in DMEM + 0.1% calf serum (CS)). In order to harvest all of the cells at the same time (after approximately 32 h in low serum), the cells that received the longest exposure to PDGF received ligand first, whereas the PDGF was added last to the cells that received the shortest stimulation with PDGF. To label the cells, 2 h prior to harvest the cells were washed with phosphate-deficient DMEM (ICN) + 0.1% CS and incubated in this medium containing 2 mCi/ml [ 32 P]orthophosphate. PDGF was included in the labeling medium for all samples receiving PDGF for 2 or more hours, whereas ligand was added to the labeling medium at the appropriate time point for cells that were exposed to PDGF for less than 2 h. Following stimulation or labeling, the cells were washed twice with 10 ml PBS, and the lipids were extracted, deacylated and analyzed by HPLC as described [40] . The data was normalized to the dpm in the PtdIns-4-P HPLC peak, a pool of phospholipids which does not change significantly upon short exposure to growth factors [40] . Exposure to PDGF for up to 8 h did not change the levels of PtdIns-4-P by more than 15%.
Lipid-rescue assay
HepG2 cells were plated in DMEM + 10% fetal bovine serum (FBS) at 4 × 10 4 cells per well in 24-well plates, and after 24 h, the cells were washed twice with 2 ml PBS and incubated in starvation medium (DMEM, 0.2% FBS) for 48 h. The cells were then exposed to PDGF (50 ng/ml) or PDGF buffer (10 mM acetic acid, 2 mg/ml bovine serum albumin) for 6 h, then the medium was removed and replaced with permeabilization buffer (100 µl PBS containing 0.05 mg/ml saponin) as well as the desired concentration of lipids. After 10 min at 25°C, the permeabilization buffer was removed, the cultures were washed once with 100 ml PBS, and then starvation medium with or without PDGF was added back to each well and the cells incubated at 37°C for a further 12 h. After a total of 18 h, the cells were pulsed with [ 3 H]thymidine, and the extent of [ 3 H] incorporation was measured as described below.
DNA-synthesis assay
HepG2 cells were plated in DMEM + 10% FBS at 4 × 10 4 cells per well in 24-well plates and after 24 h, the cells were washed twice with 2 ml PBS and incubated in starvation medium for 48 h. Cell were stimulated with PDGF buffer, PDGF (50 ng/ml) or 10% FBS for 18 h, then labeled with [ 3 H]thymidine (1 µCi/ml; NEN) for 4 h. After labeling, the cells were washed once with 1 ml PBS and twice with ice-cold 5% trichloroacetic acid and solubilized in 250 µl 0.25 N NaOH. Aliquots of lysed cells (200 µl) were neutralized with 50 ml 6 N HCl and counted by liquid scintillation counting (Beckman).
Immunoprecipitation and immunoblotting
Immunoprecipitations [56] and immunoblotting [16, 56] were performed as previously described.
In vitro PI 3-kinase assays PI 3-kinase assays were performed with immunoprecipitates of βPDGFRs as described [66] . Briefly, 5 µl immunoprecipitates in PAN (20 mM PIPES, pH 7.0, 100 mM NaCl, 2 µg/ml aprotinin) were resuspended in a reaction mixture containing 20 mM HEPES, pH 7.4, 5 mM MgCl 2 , 0.45 mM EGTA, 10 µM ATP (~5 µCi [γ-32 P]ATP) and 0.2 mg/ml phosphatidylinositol in a final reaction volume of 10 µl and incubated for 20 min at 30°C. After incubation, the reaction was stopped by the addition of 100 µl 1 M HCl and the lipids extracted with 200 µl CHCl 3 :MeOH (1:1) followed by 80 µl 1 M HCl:MeOH (1:1) and dried in a 'speed vac' (Savant). The samples were resuspended in 10 µl CHCl 3 :MeOH (1:1) and spotted onto Silica Gel 60 thin-layer chromoatography (TLC) plates (JT Baker Chromatography). The TLC plates had been pretreated with 60 mM EDTA, 2% Na tartrate and 50% EtOH and dried in a 100°C oven overnight. Chromatography of the TLC plates was in CHCl 3 :MeOH:4 N NH 4 OH (9:7:2) for approximately 2 h and then the plates were dried and autoradiographed and the extent of 32 P incorporation into PtdIns-3-P was quantitated using a PhosphorImager (Molecular Dynamics).
